Structure Therapeutics (GPCR) Announces Pricing of Upsized $476 Million Public Offering streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
FSK Prices Public Offering of $600 million 6.875% Unsecured Notes Due 2029 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Gold Royalty Completes US$34.5 Million Bought Deal Financing prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 29, 2024 Merus N.V. , a clinical-stage oncology company developing innovative, full-length multispecific antibodies , today announced the.
UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 29, 2024 (GLOBE NEWSWIRE) Merus N.V. (Nasdaq: MRUS) ("Merus", the "Company," "we" and "our"), a clinical-stage oncology company developing innovative